ATNF 180 Life Sciences Corp

Price (delayed)

$2.31

Market cap

$2.18M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$29.19

Enterprise value

$2.29M

180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined ...

Highlights
ATNF's EPS has surged by 93% year-on-year and by 44% since the previous quarter
180 Life Sciences's net income has surged by 64% YoY and by 19% QoQ
180 Life Sciences's equity has plunged by 113% YoY
The quick ratio has dropped by 67% year-on-year and by 56% since the previous quarter

Key stats

What are the main financial stats of ATNF
Market
Shares outstanding
941,590
Market cap
$2.18M
Enterprise value
$2.29M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$18.54M
EBITDA
-$18.43M
Free cash flow
-$8.09M
Per share
EPS
-$29.19
Free cash flow per share
-$12.67
Book value per share
-$1.12
Revenue per share
$0
TBVPS
$2.91
Balance sheet
Total assets
$3.44M
Total liabilities
$4.4M
Debt
$788,878
Equity
-$954,466
Working capital
-$2.23M
Liquidity
Debt to equity
-0.83
Current ratio
0.45
Quick ratio
0.17
Net debt/EBITDA
-0.01
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-237.8%
Return on equity
-1,184.7%
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATNF stock price

How has the 180 Life Sciences stock price performed over time
Intraday
1.76%
1 week
-0.43%
1 month
58.22%
1 year
117.92%
YTD
-43.05%
QTD
41.72%

Financial performance

How have 180 Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.77M
Net income
-$16.24M
Gross margin
N/A
Net margin
N/A
180 Life Sciences's net income has surged by 64% YoY and by 19% QoQ
180 Life Sciences's operating income has increased by 43% YoY and by 20% QoQ

Growth

What is 180 Life Sciences's growth rate over time

Valuation

What is 180 Life Sciences stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ATNF's EPS has surged by 93% year-on-year and by 44% since the previous quarter
180 Life Sciences's equity has plunged by 113% YoY

Efficiency

How efficient is 180 Life Sciences business performance
180 Life Sciences's return on equity has shrunk by 102% QoQ
The company's return on assets has shrunk by 61% YoY and by 16% QoQ

Dividends

What is ATNF's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATNF.

Financial health

How did 180 Life Sciences financials performed over time
The company's total assets is 22% lower than its total liabilities
The company's total assets has shrunk by 77% YoY and by 35% QoQ
The quick ratio has dropped by 67% year-on-year and by 56% since the previous quarter
ATNF's debt is 183% greater than its equity
180 Life Sciences's equity has plunged by 113% YoY
ATNF's debt to equity has soared by 90% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.